Patent Assignment
Reel/Frame 047446/0556
Security Interest
Recorded: 2018-11-07
Pages: 32
Assignor
MEREO BIOPHARMA 1 LIMITED
Executed: 2018-09-28
Assignee
KREOS CAPITAL V (UK) LIMITED
25 OLD BURLINGTON STREET, LONDON, W1S 3AN, UNITED KINGDOM
Covered Properties
(7)
5-Membered Heterocycle-Based P38 Kinase Inhibitors
5-Membered Heterocycle-Based P38 Kinase Inhibitors
5-Membered Heterocycle-Based P38 Kinase Inhibitors
5-Membered Heterocycle-Based P38 Kinase Inhibitors
Use of a Pyrazole Derivative in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Dosage Regimen for the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Dosage Regimen for the Treatment of Acute Exacerbations of Inflammatory Conditions
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 3, 2015
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 036952/0483 →
Change of Address
May 23, 2018
From: MEREO BIOPHARMA 1 LIMITED
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 046223/0457 →
Assignment of Assignor's Interest
Sep 27, 2019
From: CLARKE, CYRIL; FARRELL, COLM; PARKIN, JACQUELINE; ORFORD, COLIN
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 050527/0773 →
Assignment of Assignor's Interest
Sep 27, 2019
From: DE BUCK, STEFAN
To: NOVARTIS PHARMA AG
Reel/Frame 050527/0807 →
Assignment of Assignor's Interest
Sep 27, 2019
From: NOVARTIS PHARMA AG
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 050527/0834 →
Release of Security Interest
Jan 23, 2021
From: KREOS CAPITAL V (UK) LIMITED
To: MEREO BIOPHARMA 1 LIMINTED
Reel/Frame 055010/0654 →
Release of Security Interest
Jan 23, 2021
From: KREOS CAPITAL V (UK) LIMITED
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 055010/0696 →
Corrective Assignment to Correct the Receiving Party Name Previously Recorded at Reel: 55010 Frame: 654. Assignor(S) Hereby Confirms the Release of Security Interest .
Oct 29, 2024
From: KREOS CAPITAL V (UK) LIMITED
To: MEREP BIOPHARMA 1 LIMITED
Reel/Frame 069273/0237 →
Corrective Assignment to Correct the Spelling of the Receiving Party Data from Merep Biopharma I Limited to Mereo Biopharma 1 Limited Previously Recorded on Reel 69273 Frame 237. Assignor(S) Hereby Confirms the Corrective Assignment.
Apr 10, 2025
From: KREOS CAPITAL V (UK) LIMITED
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 070808/0578 →